The year’s transplants, which include three heart and lung procedures, mark a 20% increase for the UCSF program from the previous year, according to a July 30 news release from UCSF.
Data from the Scientific Registry of Transplant Recipients shows UCSF Health is the only U.S. lung transplant program to achieve “significantly better than expected post-transplant outcomes” for more than 13 years consecutively, the release said.
As of January, UCSF Health’s post-transplant patient survival rates are 95% at one year and 87% at three years, compared to the national average rates of 89% and 74% at one and three years, respectively.
The median survival rate for UCSF lung transplant patients has increased to 10.5 years from 3.5 years in the past 20 years, according to the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
